ONCAlert | AstraZeneca: Pioneers in Ovarian Cancer

Gastric Latest NewsMORE >>

MYL-1401O, the trastuzumab (Herceptin) biosimilar manufactured by Mylan Pharmaceuticals, has been recommended for approval by the FDA's Oncologic Drugs Advisory Committee (ODAC) in a 16-0 vote.

Latest JournalAll Journals >>

Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.